Zacks.com on MSN5h
Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and ...
Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...
The awards were made under the Company’s 2024 Inducement Stock Incentive Plan, with a grant date and vesting commencement ...
The National Kidney Foundation (NKF) is pleased to announce that Registered Dietitian, Brandon Kistler, PhD, RD, is the 2025 recipient of the Joel D. Kopple Distinguished Lecture ...
This fiscal year, the U.S. Department of Veteran Affairs has requested a total of $369.3 billion in discretionary funding that will be allocated towards resources such as health care and benefits. As ...
Barchart on MSN9h
Job Growth Disappoints in January, Despite Lower UnemploymentJanuary's job growth fell short of expectations, according to the Bureau of Labor Statistics report released Friday. Only 143,000 nonfarm payrolls were added, a decrease from December's revised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback